European Association for the Study of Diabetes
@easdnews.bsky.social
We promote excellence in #diabetes #care through #research, #networking and #education.
The European Association for the Study of Diabetes e.V. (EASD) is a membership-based academic non-profit organization. It was founded in 1965, headquartered in Germany
The European Association for the Study of Diabetes e.V. (EASD) is a membership-based academic non-profit organization. It was founded in 1965, headquartered in Germany
A limitless supply of insulin-producing beta cells?
In this new #ExpertInsights episode, Prof. Matthias Hebrok explains how researchers around the world are working on making #StemCellDerivedIslets work to reshape #T1D care.
📺👉 Watch now: easd-elearning.eu/episode/346/...
In this new #ExpertInsights episode, Prof. Matthias Hebrok explains how researchers around the world are working on making #StemCellDerivedIslets work to reshape #T1D care.
📺👉 Watch now: easd-elearning.eu/episode/346/...
November 12, 2025 at 1:03 PM
A limitless supply of insulin-producing beta cells?
In this new #ExpertInsights episode, Prof. Matthias Hebrok explains how researchers around the world are working on making #StemCellDerivedIslets work to reshape #T1D care.
📺👉 Watch now: easd-elearning.eu/episode/346/...
In this new #ExpertInsights episode, Prof. Matthias Hebrok explains how researchers around the world are working on making #StemCellDerivedIslets work to reshape #T1D care.
📺👉 Watch now: easd-elearning.eu/episode/346/...
❓Can #socialmedia improve #diabetes care? ❓
Marc Evans explores its potential - along with #AI, precision prescribing & drug value of #metformin vs #SGLT2inhibitors - in the latest episode of '5 things we don't yet know about diabetes'.
📺Watch here: easd-elearning.eu/episode/351/...
Marc Evans explores its potential - along with #AI, precision prescribing & drug value of #metformin vs #SGLT2inhibitors - in the latest episode of '5 things we don't yet know about diabetes'.
📺Watch here: easd-elearning.eu/episode/351/...
November 5, 2025 at 2:50 PM
❓Can #socialmedia improve #diabetes care? ❓
Marc Evans explores its potential - along with #AI, precision prescribing & drug value of #metformin vs #SGLT2inhibitors - in the latest episode of '5 things we don't yet know about diabetes'.
📺Watch here: easd-elearning.eu/episode/351/...
Marc Evans explores its potential - along with #AI, precision prescribing & drug value of #metformin vs #SGLT2inhibitors - in the latest episode of '5 things we don't yet know about diabetes'.
📺Watch here: easd-elearning.eu/episode/351/...
Can #CGM use of just 10 to 15 days at a time make a difference in #T2D?
Dr. @dramitaol.bsky.social explains how intermittent CGM helps personalise care, optimise treatment & support #lifestyle modifications.
🎥👉 Watch now: easd-elearning.eu/episode/345/...
#Diabetes #technology #GlycaemicControl
Dr. @dramitaol.bsky.social explains how intermittent CGM helps personalise care, optimise treatment & support #lifestyle modifications.
🎥👉 Watch now: easd-elearning.eu/episode/345/...
#Diabetes #technology #GlycaemicControl
October 22, 2025 at 12:07 PM
Can #CGM use of just 10 to 15 days at a time make a difference in #T2D?
Dr. @dramitaol.bsky.social explains how intermittent CGM helps personalise care, optimise treatment & support #lifestyle modifications.
🎥👉 Watch now: easd-elearning.eu/episode/345/...
#Diabetes #technology #GlycaemicControl
Dr. @dramitaol.bsky.social explains how intermittent CGM helps personalise care, optimise treatment & support #lifestyle modifications.
🎥👉 Watch now: easd-elearning.eu/episode/345/...
#Diabetes #technology #GlycaemicControl